Correlation Between Inhibrx and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Cue Biopharma, you can compare the effects of market volatilities on Inhibrx and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Cue Biopharma.
Diversification Opportunities for Inhibrx and Cue Biopharma
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Cue is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Inhibrx i.e., Inhibrx and Cue Biopharma go up and down completely randomly.
Pair Corralation between Inhibrx and Cue Biopharma
Given the investment horizon of 90 days Inhibrx is expected to generate 0.42 times more return on investment than Cue Biopharma. However, Inhibrx is 2.35 times less risky than Cue Biopharma. It trades about -0.03 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.1 per unit of risk. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Cue Biopharma
Performance |
| Timeline |
| Inhibrx |
| Cue Biopharma |
Inhibrx and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Cue Biopharma
The main advantage of trading using opposite Inhibrx and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |